期刊文献+

降钙素原在新生儿感染中的应用评价 被引量:9

Application evaluation of procalcitonin in diagnosis of neonatal infection
原文传递
导出
摘要 降钙素原(procalcitonin,PCT)是近年来发现的感染性疾病的标记物,研究认为在细菌所致炎症或感染性疾病中特异性升高,尤其在血流感染、细菌性与非细菌性的鉴别、抗生素的合理使用及预测疾病预后方面有重要作用,是一种有很高应用价值的诊断指标,而PCT在新生儿感染疾病诊断中并没有体现出明显的优势。本文对PCT的构成、体内来源、代谢、实验室检测方法及在新生儿感染中的应用进行综述,以更深刻了解PCT在新生儿感染性疾病诊断中的价值。 Procalcitonin (PCT) has been recognized a marker of infectious diseases for the past few years. The value of PCT is specific elevation in infectious diseases or inflammation caused by bacterial and it has an important role in the identification of bloodstream infections, bacterial and non-bacterial, rational usage of antibiotics and prediction disease prognosis. PCT is a high value diagnostic indicators. However, the PCT do not reflect a clear advantage in the diagnosis of neonatal infection. In this paper, the composition of the PCT, the source in the body of PCT, the metabolism of PCT, laboratory testing methods of PCT and its applications in neonatal infection were reviewed in order to gain a deeper understanding of the value of PCT in the neonatal diagnosis of infectious diseases.
出处 《中国小儿急救医学》 CAS 2014年第1期48-50,共3页 Chinese Pediatric Emergency Medicine
关键词 降钙素原 新生儿 感染 标记物 Procalcitonin Neonate Infection Markers
  • 相关文献

参考文献28

  • 1Monneret G,Labaune JM,Isaac C. Procalcitonin and C-reactive protein levels in neonatal infections[J].{H}Acta Paediatrica,1997,(2):209-212.
  • 2Meisner M,Tschaikowsky K,Palmaers T. Procalcitonin and CRP in septic shock:inflammatory parameters with different kinetics[J].{H}Intensive Care Medicine,1996.S13.
  • 3Enguix A,Rey C,Concha A. Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children[J].{H}Intensive Care Medicine,2001,(1):211-215.
  • 4Lee YJ,Park CH,Yun JW. Predictive comparisons of proealcitonin (PCT) level,arterial ketone body ratio (AKBR),APACHE score and multiple organ dysfunction score (MODS) in systemic inflammatory response syndrome (SIRS)[J].{H}YONSEI MEDICAL Journal,2004,(1):29-37.
  • 5Whang KT,Steinwald PM,White JC. Serum calcitonin precursors in sepsis and systemic inflammation[J].{H}Journal of Clinical Endocrinology and Metabolism,1998,(9):3296-3301.
  • 6Gendrel D,Bohuon C. Procalcitonin,a marker of bacterial infection[J].{H}INFECTION,1997,(3):133-134.
  • 7Braithwaite S. Procalcitonin:new insights on regulation and origin[J].{H}CRITICAL CARE MEDICINE,2000,(2):586-588.
  • 8Oberhoffer M,Stonāns I,Russwurm S. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro[J].{H}Journal of Laboratory and Clinical Medicine,1999,(1):49-55.
  • 9Nylen E,Muller B,Snider R. 51 pathophysiologial significance of calcitonin precursors in sepsis and systemic inflammation[J].{H}SHOCK,1999,(6):14.
  • 10Oski FA,Naiman JL. Normal hematologic values of the newborn.Hematologic problems of the newborn[M].{H}Philadelphia:WB Saunders,1982.1-32.

二级参考文献49

共引文献170

同被引文献110

  • 1白桂芹,付逢萍,唐瑶.乙型肝炎病毒x抗原在HBV宫内感染中的作用机制[J].西安交通大学学报(医学版),2012,33(5):631-635. 被引量:1
  • 2李兴周,沈丽萍.降钙素原在婴幼儿重症肺炎诊治中的价值[J].临床儿科杂志,2007,25(11):923-925. 被引量:19
  • 3Patria MF,Longhi B,Lelii M,et al.Association between radiological findings and severity of community-acquired pneumonia in children[J].Ital J Pediatr,2013,39(1):56-58.
  • 4Das RR,Singh M.Treatment of severe community-acquired pneumonia with oral amoxicillin in under-five children in developing country:a systematic review[J].PLoS One,2013,8 (6):e66232-e66235.
  • 5Rudan I,O' Brien KL,Nair H,et al.Epidemiology and etiology of childhood pneumonia in 2010:estimates of incidence,severe morbidity,mortality,underlying risk factors and causative pathogens for 192 countries[J].J Glob Health,2013,3 (1):10401-10405.
  • 6Pourakbari B,Mamishi S,Zafari J,et al.Evaluation of procalcitonin and neopterin level in serum of patients with acute bacterial infection[J].Braz J Infect Dis,2010,14(3):252-255.
  • 7Esposito S,Tagliabue C,Picciolli I,et al.Procalcitonin measurements for guiding antibiotic treatment in pediatric pneumonia[J].Respir Med,2011,105 (12):1939-1945.
  • 8Seligman R,Ramos-Lima LF,Oliveira Vdo A,et al.Biomarkers in community-acquired pneumonia:a state-of-the-art review[J].Clinics (Sao Paulo),2012,67(11):1321-1325.
  • 9Lee JY,Hwang SJ,Shim JW,et al.Clinical significance of serum procalcitonin in patients with community-acquired lobar pneumonia[J].Korean J Lab Med,2010,30(4):406-413.
  • 10Kim JH,Seo JW,Mok JH,et al.Usefulness of plasma procalcitonin to predict severity in elderly patients with community-acquired pneumonia[J].Tuberc Respir Dis(Seoul),2013,74(5):207-214.

引证文献9

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部